Mangoceuticals (MGRX) Operating Margin (2023 - 2025)
Historic Operating Margin for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to 8953.45%.
- Mangoceuticals' Operating Margin fell 76352400.0% to 8953.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 4142.63%, marking a year-over-year decrease of 29688000.0%. This contributed to the annual value of 1294.42% for FY2024, which is 341400.0% down from last year.
- As of Q3 2025, Mangoceuticals' Operating Margin stood at 8953.45%, which was down 76352400.0% from 3133.98% recorded in Q2 2025.
- In the past 5 years, Mangoceuticals' Operating Margin ranged from a high of 733.99% in Q3 2023 and a low of 8953.45% during Q3 2025
- Its 3-year average for Operating Margin is 2529.39%, with a median of 1594.02% in 2024.
- As far as peak fluctuations go, Mangoceuticals' Operating Margin soared by 14349100bps in 2024, and later plummeted by -76352400bps in 2025.
- Over the past 3 years, Mangoceuticals' Operating Margin (Quarter) stood at 1050.87% in 2023, then crashed by -52bps to 1594.02% in 2024, then tumbled by -462bps to 8953.45% in 2025.
- Its Operating Margin stands at 8953.45% for Q3 2025, versus 3133.98% for Q2 2025 and 4440.0% for Q1 2025.